FDA Inspection 738907 — King Bio Inc.

King Bio Inc. — FEI 1053442

The FDA completed an inspection of King Bio Inc. on Aug 10, 2011 in Asheville, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 10, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Asheville, NC (United States)

Citations

IDCFRDescription
111121 CFR 211.25(a)Training , Education , Experience overall
185121 CFR 211.84(e)Rejecting When Specifications Not Met
188521 CFR 211.165(b)Microbiological testing
191221 CFR 211.166(a)Written program not followed
202621 CFR 211.192Quality control unit review of records
220521 CFR 211.186(b)(9)Manufacturing Instructions and Specifications

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.